Bullous pemphigoid induced by dipeptidyl peptidase-4 (DPP-4) inhibitors: A Pharmacovigilance-Pharmacodynamic/Pharmacokinetic assessment through an analysis of the VigiBase®

Carla Carnovale,Faizan Mazhar,Elena Arzenton,Ugo Moretti,Marco Pozzi,Giulia Mosini,Olivia Leoni,Marco Scatigna,Emilio Clementi,Sonia Radice

Bullous pemphigoid induced by dipeptidyl peptidase-4 (DPP-4) inhibitors: A Pharmacovigilance-Pharmacodynamic/Pharmacokinetic assessment through an analysis of the VigiBase®

2019

Carla Carnovale
Faizan Mazhar
Elena Arzenton
Ugo Moretti
Marco Pozzi
Giulia Mosini
Olivia Leoni
Marco Scatigna
Emilio Clementi
Sonia Radice

AbstractObjectives: To examine the signals of bullous pemphigoid (BP) with dipeptidyl peptidase-4 (DPP-4) inhibitors in VigiBase® and the potential role of pharmacodynamic/pharmacokinetic parameter...

Keywords:

DPP-4 Inhibitors
Bullous pemphigoid
Pharmacology
Pharmacodynamics
Medicine
Dipeptidyl peptidase-4
Pharmacovigilance
Pharmacokinetics
Diabetes mellitus

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations